Hereditary Testing Market Size, Share, Trends, Growth Outlook

Hereditary Testing Market is estimated to increase at a growth rate of 8.1% CAGR over the forecast period from 2024 to 2030.

The Hereditary Testing Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Disease Type (Hereditary Cancer Testing, Hereditary Non-cancer Testing), By Technology (Cytogenetic, Biochemical, Molecular Testing).

 

An Introduction to Hereditary Testing Market in 2024

The hereditary testing market in 2024 caters to the demand for genetic testing services and personalized medicine approaches used in the identification, risk assessment, and management of inherited genetic disorders and hereditary conditions, enabling individuals and families to make informed decisions about health, reproductive choices, and disease prevention strategies based on their genetic predispositions and familial risk factors. Hereditary testing encompasses a wide range of tests, including carrier screening, prenatal testing, predictive genetic testing, and pharmacogenetic testing, which analyze DNA sequences, mutations, and genetic variants associated with hereditary diseases, cancer susceptibility, and drug metabolism, providing actionable insights for disease prevention, early intervention, and personalized treatment planning in clinical and preventive medicine settings. Market dynamics are driven by factors such as the growing demand for personalized healthcare, advancements in genomic sequencing technologies, and the expansion of genetic testing applications in oncology, cardiology, and rare disease diagnosis. Collaboration between genetic testing providers, healthcare professionals, and patient advocacy groups drives innovation and market development in hereditary testing, enabling the integration of genetics into routine clinical practice and population health management initiatives to improve health outcomes and reduce disease burden across diverse patient populations.

 

Hereditary Testing Market Trend: Increasing Demand for Personalized Medicine

A significant trend in the Hereditary Testing market is the rising demand for personalized medicine driven by advances in genomic technology. As the understanding of genetic predispositions to various diseases improves, there is growing interest in hereditary testing to assess an individual's risk of developing inherited conditions or drug responses. This trend is fueled by the recognition that personalized genetic information can inform healthcare decisions, including disease prevention, early detection, treatment selection, and monitoring. Moreover, advancements in sequencing technologies and bioinformatics have made hereditary testing more accessible, affordable, and comprehensive, driving its adoption in both clinical and direct-to-consumer settings.

Hereditary Testing Market Driver: Growing Awareness of Genetic Risks and Benefits

A key driver in the Hereditary Testing market is the growing awareness among individuals and healthcare providers of the benefits of genetic testing for assessing hereditary risks. With increasing knowledge about the role of genetics in disease susceptibility and treatment response, there is a heightened interest in understanding one's genetic makeup to make informed healthcare decisions. Factors such as family history of genetic disorders, the desire for proactive health management, and the availability of targeted therapies based on genetic profiles are driving the demand for hereditary testing. Additionally, the integration of genetic counseling services into testing programs enhances the utility of genetic information by providing guidance on interpretation, risk assessment, and personalized healthcare planning.

Hereditary Testing Market Opportunity: Expansion into Direct-to-Consumer Market

An opportunity for market growth in the Hereditary Testing market lies in the expansion into the direct-to-consumer (DTC) segment. With increasing consumer empowerment and interest in personalized health information, there is a growing market for DTC genetic testing services that offer insights into ancestry, health traits, and hereditary risks. By leveraging digital platforms, online marketing strategies, and user-friendly testing kits, companies can tap into the DTC market to reach a broader consumer base interested in exploring their genetic heritage and health predispositions. Moreover, offering educational resources and genetic counseling support can enhance consumer trust, engagement, and satisfaction with DTC hereditary testing services.

 

Hereditary Testing Market Segmentation

 

By Disease Type

Hereditary Cancer Testing

-Lung Cancer

-Breast Cancer

-Colorectal Cancer

-Cervical Cancer

-Ovarian Cancer

-Prostate Cancer

-Stomach/Gastric Cancer

-Melanoma

-Sarcoma

-Uterine Cancer

-Pancreatic Cancer

-Others

Hereditary Non-cancer Testing

-Genetic Tests

-Cardiac Diseases

-Rare Diseases

-Others

-Preimplantation Genetic Diagnosis & Screening

-Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests

-Newborn Genetic Screening

By Technology

Cytogenetic

Biochemical

Molecular Testing

 

Geographical Analysis

North America (United States, Canada, Mexico)

Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

 

Hereditary Testing Market Companies

Agilent Technologies Inc

CENTOGENE N.V.

COOPERSURGICAL Inc

F. Hoffmann-La Roche Ltd

Fulgent Genetics

Illumina Inc

Invitae Corp

Laboratory Corp of America Holdings

MedGenome

Myriad Genetics Inc

Natera Inc

Quest Diagnostics Inc

SOPHiA GENETICS

Thermo Fisher Scientific Inc

Twist Bioscience

*- List Not Exhaustive

 

Reasons to Buy the Hereditary Testing Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions

• Gain access to detailed insights on the Hereditary Testing Market, encompassing current market size, growth trends, and forecasts till 2030.

• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities

• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends

• Identify lucrative investment avenues and expansion opportunities within the Hereditary Testing Market industry, guided by robust, data-backed analysis.

• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics

• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain

• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics

• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

 

1 Introduction to 2024 Hereditary Testing Market

1.1 Market Overview

1.2 Quick Facts

1.3 Scope/Objective of the Study

1.4 Market Definition

1.5 Countries and Regions Analyzed

1.6 Units, Currency, and Conversions

1.7 Industry Value Chain

 

2 Research Methodology

2.1 Market Size Estimation

2.2 Sources and Research Methodology

2.3 Data Triangulation

2.4 Assumptions and Limitations

 

3 Executive Summary

3.1 Global Hereditary Testing Market Size Outlook, $ Million, 2021 to 2030

3.2 Hereditary Testing Market Outlook by Type, $ Million, 2021 to 2030

3.3 Hereditary Testing Market Outlook by Product, $ Million, 2021 to 2030

3.4 Hereditary Testing Market Outlook by Application, $ Million, 2021 to 2030

3.5 Hereditary Testing Market Outlook by Key Countries, $ Million, 2021 to 2030

 

4 Market Dynamics

4.1 Key Driving Forces of Hereditary Testing Market Industry

4.2 Key Market Trends in Hereditary Testing Market Industry

4.3 Potential Opportunities in Hereditary Testing Market Industry

4.4 Key Challenges in Hereditary Testing Market Industry

 

5 Market Factor Analysis

5.1 Competitive Landscape

5.1.1 Global Hereditary Testing Market Share by Company (%), 2023

5.1.2 Product Offerings by Company

5.2 Porter’s Five Forces Analysis

 

6 Growth Outlook Across Scenarios

6.1 Growth Analysis-Case Scenario Definitions

6.2 Low Growth Scenario Forecasts

6.3 Reference Growth Scenario Forecasts

6.4 High Growth Scenario Forecasts

 

7 Global Hereditary Testing Market Outlook By Segments

7.1 Hereditary Testing Market Outlook by Segments

By Disease Type

Hereditary Cancer Testing

-Lung Cancer

-Breast Cancer

-Colorectal Cancer

-Cervical Cancer

-Ovarian Cancer

-Prostate Cancer

-Stomach/Gastric Cancer

-Melanoma

-Sarcoma

-Uterine Cancer

-Pancreatic Cancer

-Others

Hereditary Non-cancer Testing

-Genetic Tests

-Cardiac Diseases

-Rare Diseases

-Others

-Preimplantation Genetic Diagnosis & Screening

-Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests

-Newborn Genetic Screening

By Technology

Cytogenetic

Biochemical

Molecular Testing

 

8 North America Hereditary Testing Market Analysis And Outlook To 2030

8.1 Introduction to North America Hereditary Testing Markets in 2024

8.2 North America Hereditary Testing Market Size Outlook by Country, 2021-2030

8.2.1 United States

8.2.2 Canada

8.2.3 Mexico

8.3 North America Hereditary Testing Market size Outlook by Segments, 2021-2030

By Disease Type

Hereditary Cancer Testing

-Lung Cancer

-Breast Cancer

-Colorectal Cancer

-Cervical Cancer

-Ovarian Cancer

-Prostate Cancer

-Stomach/Gastric Cancer

-Melanoma

-Sarcoma

-Uterine Cancer

-Pancreatic Cancer

-Others

Hereditary Non-cancer Testing

-Genetic Tests

-Cardiac Diseases

-Rare Diseases

-Others

-Preimplantation Genetic Diagnosis & Screening

-Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests

-Newborn Genetic Screening

By Technology

Cytogenetic

Biochemical

Molecular Testing

 

9 Europe Hereditary Testing Market Analysis And Outlook To 2030

9.1 Introduction to Europe Hereditary Testing Markets in 2024

9.2 Europe Hereditary Testing Market Size Outlook by Country, 2021-2030

9.2.1 Germany

9.2.2 France

9.2.3 Spain

9.2.4 United Kingdom

9.2.4 Italy

9.2.5 Russia

9.2.6 Norway

9.2.7 Rest of Europe

9.3 Europe Hereditary Testing Market Size Outlook By Segments, 2021-2030

By Disease Type

Hereditary Cancer Testing

-Lung Cancer

-Breast Cancer

-Colorectal Cancer

-Cervical Cancer

-Ovarian Cancer

-Prostate Cancer

-Stomach/Gastric Cancer

-Melanoma

-Sarcoma

-Uterine Cancer

-Pancreatic Cancer

-Others

Hereditary Non-cancer Testing

-Genetic Tests

-Cardiac Diseases

-Rare Diseases

-Others

-Preimplantation Genetic Diagnosis & Screening

-Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests

-Newborn Genetic Screening

By Technology

Cytogenetic

Biochemical

Molecular Testing

 

10 Asia Pacific Hereditary Testing Market Analysis And Outlook To 2030

10.1 Introduction to Asia Pacific Hereditary Testing Markets in 2024

10.2 Asia Pacific Hereditary Testing Market Size Outlook by Country, 2021-2030

10.2.1 China

10.2.2 India

10.2.3 Japan

10.2.4 South Korea

10.2.5 Indonesia

10.2.6 Malaysia

10.2.7 Australia

10.2.8 Rest of Asia Pacific

10.3 Asia Pacific Hereditary Testing Market size Outlook by Segments, 2021-2030

By Disease Type

Hereditary Cancer Testing

-Lung Cancer

-Breast Cancer

-Colorectal Cancer

-Cervical Cancer

-Ovarian Cancer

-Prostate Cancer

-Stomach/Gastric Cancer

-Melanoma

-Sarcoma

-Uterine Cancer

-Pancreatic Cancer

-Others

Hereditary Non-cancer Testing

-Genetic Tests

-Cardiac Diseases

-Rare Diseases

-Others

-Preimplantation Genetic Diagnosis & Screening

-Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests

-Newborn Genetic Screening

By Technology

Cytogenetic

Biochemical

Molecular Testing

 

11 South America Hereditary Testing Market Analysis And Outlook To 2030

11.1 Introduction to South America Hereditary Testing Markets in 2024

11.2 South America Hereditary Testing Market Size Outlook by Country, 2021-2030

11.2.1 Brazil

11.2.2 Argentina

11.2.3 Rest of South America

11.3 South America Hereditary Testing Market size Outlook by Segments, 2021-2030

By Disease Type

Hereditary Cancer Testing

-Lung Cancer

-Breast Cancer

-Colorectal Cancer

-Cervical Cancer

-Ovarian Cancer

-Prostate Cancer

-Stomach/Gastric Cancer

-Melanoma

-Sarcoma

-Uterine Cancer

-Pancreatic Cancer

-Others

Hereditary Non-cancer Testing

-Genetic Tests

-Cardiac Diseases

-Rare Diseases

-Others

-Preimplantation Genetic Diagnosis & Screening

-Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests

-Newborn Genetic Screening

By Technology

Cytogenetic

Biochemical

Molecular Testing

 

12 Middle East And Africa Hereditary Testing Market Analysis And Outlook To 2030

12.1 Introduction to Middle East and Africa Hereditary Testing Markets in 2024

12.2 Middle East and Africa Hereditary Testing Market Size Outlook by Country, 2021-2030

12.2.1 Saudi Arabia

12.2.2 UAE

12.2.3 Oman

12.2.4 Rest of Middle East

12.2.5 Egypt

12.2.6 Nigeria

12.2.7 South Africa

12.2.8 Rest of Africa

12.3 Middle East and Africa Hereditary Testing Market size Outlook by Segments, 2021-2030

By Disease Type

Hereditary Cancer Testing

-Lung Cancer

-Breast Cancer

-Colorectal Cancer

-Cervical Cancer

-Ovarian Cancer

-Prostate Cancer

-Stomach/Gastric Cancer

-Melanoma

-Sarcoma

-Uterine Cancer

-Pancreatic Cancer

-Others

Hereditary Non-cancer Testing

-Genetic Tests

-Cardiac Diseases

-Rare Diseases

-Others

-Preimplantation Genetic Diagnosis & Screening

-Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests

-Newborn Genetic Screening

By Technology

Cytogenetic

Biochemical

Molecular Testing

 

13 Company Profiles

13.1  Company Snapshot

13.2 SWOT Profiles

13.3 Products and Services

13.4 Recent Developments

13.5 Financial Profile

List of Companies

Agilent Technologies Inc

CENTOGENE N.V.

COOPERSURGICAL Inc

F. Hoffmann-La Roche Ltd

Fulgent Genetics

Illumina Inc

Invitae Corp

Laboratory Corp of America Holdings

MedGenome

Myriad Genetics Inc

Natera Inc

Quest Diagnostics Inc

SOPHiA GENETICS

Thermo Fisher Scientific Inc

Twist Bioscience

 

14 Appendix

14.1 Customization Offerings

14.2 Subscription Services

14.3 Related Reports

14.4 Publisher Expertise

Hereditary Testing Market Segmentation

 

By Disease Type

Hereditary Cancer Testing

-Lung Cancer

-Breast Cancer

-Colorectal Cancer

-Cervical Cancer

-Ovarian Cancer

-Prostate Cancer

-Stomach/Gastric Cancer

-Melanoma

-Sarcoma

-Uterine Cancer

-Pancreatic Cancer

-Others

Hereditary Non-cancer Testing

-Genetic Tests

-Cardiac Diseases

-Rare Diseases

-Others

-Preimplantation Genetic Diagnosis & Screening

-Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests

-Newborn Genetic Screening

By Technology

Cytogenetic

Biochemical

Molecular Testing

 

Geographical Analysis

North America (United States, Canada, Mexico)

Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)